An update on pharmacological approaches to neurodegenerative diseases.
about
Indole alkaloids from Catharanthus roseus: bioproduction and their effect on human healthMeeting the unique challenges of drug discovery for neurodegenerative diseasesNovel nootropic drug sunifiram enhances hippocampal synaptic efficacy via glycine-binding site of N-methyl-D-aspartate receptor.A broadly neuroprotective derivative of curcumin.Amyloid precursor protein 96-110 and beta-amyloid 1-42 elicit developmental anomalies in sea urchin embryos and larvae that are alleviated by neurotransmitter analogs for acetylcholine, serotonin and cannabinoidsDonepezil for Alzheimer's disease.Therapeutic perspectives for the treatment of Huntington's disease: treating the whole bodyBringing natural products into the fold - exploring the therapeutic lead potential of secondary metabolites for the treatment of protein-misfolding-related neurodegenerative diseases.Functional proteomics: application of mass spectrometry to the study of enzymology in complex mixtures.Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis.Low-Affinity Neurotrophin Receptor p75 Promotes the Transduction of Targeted Lentiviral Vectors to Cholinergic Neurons of Rat Basal Forebrain.THC (Δ9-Tetrahydrocannabinol) Exerts Neuroprotective Effect in Glutamate-affected Murine Primary Mesencephalic Cultures Through Restoring Mitochondrial Membrane Potential and Anti-apoptosis Involving CB1 Receptor-dependent Mechanism.Injectable uncrosslinked biomimetic hydrogels as candidate scaffolds for neural stem cell delivery.Pharmacological effects of active compounds on neurodegenerative disease with gastrodia and uncaria decoction, a commonly used poststroke decoction.
P2860
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
P2860
An update on pharmacological approaches to neurodegenerative diseases.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
An update on pharmacological approaches to neurodegenerative diseases.
@ast
An update on pharmacological approaches to neurodegenerative diseases.
@en
type
label
An update on pharmacological approaches to neurodegenerative diseases.
@ast
An update on pharmacological approaches to neurodegenerative diseases.
@en
prefLabel
An update on pharmacological approaches to neurodegenerative diseases.
@ast
An update on pharmacological approaches to neurodegenerative diseases.
@en
P2093
P2860
P356
P1476
An update on pharmacological approaches to neurodegenerative diseases.
@en
P2093
Bruno Giardina
Giorgia Botta
Giuseppe E Martorana
Paola Pastore
Patrizia Bottoni
Roberto Scatena
P2860
P356
10.1517/13543784.16.1.59
P407
P577
2007-01-01T00:00:00Z